What Changed in the Price Target Narrative Analysts lifting their Prothena price target to US$36, from US$15, are tying that view to how they see the partnered pipeline converting into future royalty ...

The latest price target for Century Therapeutics (NASDAQ:IPSC) was reported by Leerink Partners on November 17, 2025. The analyst firm set a price target for $2.00 expecting IPSC to rise to within 12 ...

Combining a payload of shot with a light-for-caliber bullet, DoubleTap Ammunition's new SnakeShot Defense load provides a ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

An announcement from Century Therapeutics ( ($IPSC) ) is now available. On December 18, 2025, Century Therapeutics, Inc. announced that board ...

Evotec AG ( ($EVO) ) has shared an announcement. On January 1, 2026, Evotec SE announced the appointment of Dr. Sarah Fakih as Executive Vice ...

For as long as she could remember, Dina Radenkovic was a meticulous planner, determined to leave as little as possible to ...

This flexible side-by-side from Heritage Manufacturing is ready for a variety of shooting roles including turkey hunting!

In a groundbreaking twist on IVF, Dina Radenkovic's innovative company, Gameto, is changing the face of motherhood by ...

Creation of new Executive Vice President role integrating Global Communications and Investor Relations to strengthen strategic messaging and stakeholder alignment HAMBURG, DE / ACCESS Newswire / ...

Detailed price information for Century Therapeutics Inc (IPSC-Q) from The Globe and Mail including charting and trades.